Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People with any type of diabetes that has been diagnosed for at least 1 year, who manage it using multiple daily insulin injections or an insulin pump
- People who are currently wearing a continuous glucose monitor (a device that tracks blood sugar levels throughout the day) and have been using it for more than 70% of the time over the last 4 weeks
- People who are not expected to have any changes to their diabetes treatment in the next 6 months, such as starting new medications or a new type of insulin delivery system
- People whose continuous glucose monitor data shows blood sugar levels that vary widely and spend less than 70% of the time in a healthy target range (confirm with trial site for exact measurements)
- People who are willing and able to follow the study requirements, including having two ultrasound scans of their insulin injection sites
- People who can understand English well enough to safely take part in the study
Who may not be able to join:
- People with another physical illness or a known severe mental illness that the trial doctor believes could interfere with the study
- People who have been diagnosed with any form of a condition that causes abnormal fat tissue distribution (lipodystrophy), whether inherited or caused by another medical condition
- People who have a condition called Dercum's disease, which involves painful fatty tissue growths
- Women who are currently pregnant or planning to become pregnant
- People who have a serious, life-threatening illness where life expectancy is less than 6 months
- People whose kidneys are not functioning well enough, based on a specific blood test result (confirm with trial site for exact threshold)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lalantha Leelarathna, PhD FRCP, Imperial College London
Phone: +447984477771
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time in Range (3.9 to 10.0 mmol/l)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.